Misook Yu

Array ( [id] => 4683161 [patent_doc_number] => 20080249387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Enhanced monitor compliance' [patent_app_type] => utility [patent_app_number] => 12/080318 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4097 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249387.pdf [firstpage_image] =>[orig_patent_app_number] => 12080318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4561088 [patent_doc_number] => 07846447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction' [patent_app_type] => utility [patent_app_number] => 12/077508 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7461 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846447.pdf [firstpage_image] =>[orig_patent_app_number] => 12077508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727235 [patent_doc_number] => 20080206777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors' [patent_app_type] => utility [patent_app_number] => 12/072651 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11130 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206777.pdf [firstpage_image] =>[orig_patent_app_number] => 12072651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718542 [patent_doc_number] => 20080241064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN' [patent_app_type] => utility [patent_app_number] => 12/036875 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26583 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241064.pdf [firstpage_image] =>[orig_patent_app_number] => 12036875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676152 [patent_doc_number] => 20080213782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'SOCS-1 Gene Methylation in Cancer' [patent_app_type] => utility [patent_app_number] => 12/036182 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29224 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213782.pdf [firstpage_image] =>[orig_patent_app_number] => 12036182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196334 [patent_doc_number] => 07635759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Gene encoding labyrinthin, a marker for cancer' [patent_app_type] => utility [patent_app_number] => 12/029113 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8291 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635759.pdf [firstpage_image] =>[orig_patent_app_number] => 12029113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132307 [patent_doc_number] => 07695915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/012530 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 27980 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/695/07695915.pdf [firstpage_image] =>[orig_patent_app_number] => 12012530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374570 [patent_doc_number] => 20100081153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'CANCER ASSOCIATED PROTEIN KINASES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/018110 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24062 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081153.pdf [firstpage_image] =>[orig_patent_app_number] => 12018110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739464 [patent_doc_number] => 20080233117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'REDUCING TUMOR GROWTH' [patent_app_type] => utility [patent_app_number] => 12/016062 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7616 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233117.pdf [firstpage_image] =>[orig_patent_app_number] => 12016062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545371 [patent_doc_number] => 20090155248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Antibodies to MT-SP1 serine protease' [patent_app_type] => utility [patent_app_number] => 12/014067 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 36417 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155248.pdf [firstpage_image] =>[orig_patent_app_number] => 12014067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681807 [patent_doc_number] => 20080248033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors' [patent_app_type] => utility [patent_app_number] => 12/002605 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 46398 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248033.pdf [firstpage_image] =>[orig_patent_app_number] => 12002605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6580520 [patent_doc_number] => 20100129791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product' [patent_app_type] => utility [patent_app_number] => 11/956680 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22689 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129791.pdf [firstpage_image] =>[orig_patent_app_number] => 11956680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751951 [patent_doc_number] => 20080160024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'INHIBITION OF CANCER METASTASIS' [patent_app_type] => utility [patent_app_number] => 11/952198 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8023 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160024.pdf [firstpage_image] =>[orig_patent_app_number] => 11952198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903550 [patent_doc_number] => 20080112963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Ablative immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/936221 [patent_app_country] => US [patent_app_date] => 2007-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6109 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112963.pdf [firstpage_image] =>[orig_patent_app_number] => 11936221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880543 [patent_doc_number] => 20080153926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING MITOCHONDRIAL ALDERHYDE DEHYDROGENASE-2' [patent_app_type] => utility [patent_app_number] => 11/868796 [patent_app_country] => US [patent_app_date] => 2007-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14728 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153926.pdf [firstpage_image] =>[orig_patent_app_number] => 11868796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6483152 [patent_doc_number] => 20100008928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'AGENT FOR PREVENTING/TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/444382 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 75760 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008928.pdf [firstpage_image] =>[orig_patent_app_number] => 12444382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676147 [patent_doc_number] => 20080213777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Tumor suppressor pathway in C. elegans' [patent_app_type] => utility [patent_app_number] => 11/973006 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17441 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213777.pdf [firstpage_image] =>[orig_patent_app_number] => 11973006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574967 [patent_doc_number] => 20090142328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Uses of antileukoprotease in carcinoma' [patent_app_type] => utility [patent_app_number] => 11/906596 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6633 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142328.pdf [firstpage_image] =>[orig_patent_app_number] => 11906596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867453 [patent_doc_number] => 20080146512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Cyclin-dependent kinase inhibitors as targets for opiod growth factor treatment' [patent_app_type] => utility [patent_app_number] => 11/901770 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14930 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146512.pdf [firstpage_image] =>[orig_patent_app_number] => 11901770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964848 [patent_doc_number] => 20080107668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/846872 [patent_app_country] => US [patent_app_date] => 2007-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18456 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107668.pdf [firstpage_image] =>[orig_patent_app_number] => 11846872 [rel_patent_id] =>[rel_patent_doc_number] =>)